These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 812628)

  • 1. Patient package inserts. II. Toward a rational patient package insert.
    Joubert P; Lasagna L
    Clin Pharmacol Ther; 1975 Dec; 18(6):663-9. PubMed ID: 812628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commentary: Patient package inserts. I. Nature, notions, and needs.
    Joubert P; Lasagna L
    Clin Pharmacol Ther; 1975 Nov; 18(5 Pt 1):507-13. PubMed ID: 1183137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influence of the drug package information paper on compliance of neurological and psychiatric outpatients].
    Weitbrecht WU; Vosskämper C
    Fortschr Neurol Psychiatr; 2002 Apr; 70(4):178-84. PubMed ID: 11948431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Package inserts for antihypertensive drugs: use by the patients and impact on adverse drug reactions.
    Van Haecht CH; Vander Stichele R; Bogaert MG
    Eur J Clin Pharmacol; 1990; 39(6):551-4. PubMed ID: 2095340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attitudes of private medical practitioners towards package inserts and other drug information sources.
    Joubert PH; Skene D
    S Afr Med J; 1984 Aug; 66(8):306-7. PubMed ID: 6474294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What information for the patient? Large scale pilot study on experimental package inserts giving information on prescribed and over the counter drugs.
    Servizio di Informazione e di Educazione Sanitaria
    BMJ; 1990 Dec; 301(6763):1261-5. PubMed ID: 2271829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients' understanding of prescribed drugs.
    Fletcher SW; Fletcher RH; Thomas DC; Hamann C
    J Community Health; 1979; 4(3):183-9. PubMed ID: 457923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer communication patterns and the influence of patient characteristics: disparities in information-giving and affective behaviors.
    Siminoff LA; Graham GC; Gordon NH
    Patient Educ Couns; 2006 Sep; 62(3):355-60. PubMed ID: 16860520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A 30-year history of the change in package insert for Japanese pharmaceutical medicines].
    Sasaki K; Kondo T
    Yakushigaku Zasshi; 2004; 39(2):276-85. PubMed ID: 16025649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Assessment of the comprehension of new rephrasing drug package inserts].
    Miquel AV; Ortín Font F; Marrugat J; Pavesi M
    Med Clin (Barc); 2000 Oct; 115(11):410-7. PubMed ID: 11093843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthcare decisions and product labeling: results of a consumer comprehension study of prototype labeling for proposed over-the-counter cholestyramine.
    Friedman CP; Romeo D; Hinton SS
    Am J Med; 1997 Feb; 102(2A):50-6. PubMed ID: 9217587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitude of physicians toward patient package inserts for medication information in Belgium.
    Stichele RH; De Potter B; Vyncke P; Bogaert MG
    Patient Educ Couns; 1996 Jun; 28(1):5-13. PubMed ID: 8852202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The patient's understanding of the oral contraceptive patient package insert.
    Casey FG; Fluitt DM; Wiatt AL
    Mil Med; 1983 Mar; 148(3):276-8. PubMed ID: 6408516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attitudes toward the patient package insert--a survey of physicians and pharmacists.
    Fleckenstein L
    Drug Inf J; 1977; 11(1):23-9. PubMed ID: 10304966
    [No Abstract]   [Full Text] [Related]  

  • 15. Home medication cabinets and self-medication: a source of potential health threats?
    De Bolle L; Mehuys E; Adriaens E; Remon JP; Van Bortel L; Christiaens T
    Ann Pharmacother; 2008 Apr; 42(4):572-9. PubMed ID: 18364405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA.
    Mintzes B; Barer ML; Kravitz RL; Bassett K; Lexchin J; Kazanjian A; Evans RG; Pan R; Marion SA
    CMAJ; 2003 Sep; 169(5):405-12. PubMed ID: 12952801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between patient age and duration of physician visit in ambulatory setting: does one size fit all?
    Lo A; Ryder K; Shorr RI
    J Am Geriatr Soc; 2005 Jul; 53(7):1162-7. PubMed ID: 16108934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformity of package inserts information to regulatory requirements among selected branded and generic medicinal products circulating on the East African market.
    Sillo HB; Masota NE; Kisoma S; Rago L; Mgoyela V; Kaale EA
    PLoS One; 2018; 13(5):e0197490. PubMed ID: 29787579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women's information-seeking behavior after receiving contraceptive versus noncontraceptive prescriptions.
    Russo JA; Parisi SM; Kukla K; Schwarz EB
    Contraception; 2013 Jun; 87(6):824-9. PubMed ID: 23121825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Improvement of package insert CYP information for prescription drugs marketed in Japan].
    Hirata-Koizumi M; Saito M; Urano T; Miyake S; Hasegawa R
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2005; (123):12-8. PubMed ID: 16541745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.